The potential usefulness of NfL levels in predicting CBS severity and progression may be derived from evidence regarding other neurodegenerative dementias[41]; indeed, high CSF and plasma NfL levels have been associated with MCI secondary to AD [45, 46] and with more severe disease in AD patients [47]. This evidence concerns the gene NEFL and Alzheimer disease.